JILL FELDMAN

LUNG CANCER ADVOCATE Accelerate lung cancer research through collaborations with clinicians and scientists and as liaison between patient community and researchers/physicians Bring the collective patient perspective to the planning and implementation of clinical studies Embed a health equity lens in my work on initiatives and programs Provide support to those living with lung cancer and their families Raise awareness at the local, national, and international level

• OncoDaily’s top 100 Influential Women in Oncology, 2023
• LUNGevity Foundation Face of Hope Award, 2020
• CONQUER, Hero of Hope Award, 2015
• National Women’s Survivor Convention Inaugural Event, Honored Guest, 2013
• Make it Better, October 12, 2011, Thanks for Giving
• AACR Scientist Survivor Program, 2019, 2021
• Mentor and contributor IASLC Supportive Training for Advocates in Research and Science (STARS), 2019, 2021, 2022, 2023
• ASCO/AACR Methods Clinical Cancer Research, 2022 – present
• Research Advocacy Network, Advocate Institute, 2010

• Peer Review
• Conquer Cancer GSC, 2022-present
• EGFR Resisters & LUNGevity Foundation Grants, 2020 – present
• DOD CDMRP LCRP Consumer Reviewer, 2012-2018
• PCORI – 2020-2021

• Conferences
• ESMO 2023, Disrupting the Paradigm in Early Phase Trials
• NLCRT Annual Meeting 2023, Patient Perspective: Population vs Individual Risk Assessment for Lung Cancer Screening Eligibility
• NLCRT Annual Meeting 2023, Patient Panel, Learning from Patients’ lived Experience, moderator and speaker
• ASTRO 2023, The Future of Treating OMD in NSCLC: Dismantling the One-Size-Fits-All Approach
• IASLC WCLC Opening Plenary 2023, Introduction of HRH Princess Dina Mired
• IASLC WCLC Press Conference 2023, Recognizing Early Adopters of Non-Stigmatizing Language at WCLC 2022
• ASCO Case-Based Panel 2023, A Patient’s Journey from Early Stage to Metastatic Lung Cancer
• IASLC TTLC 2023, The Patient Voice in Clinical Trial Development
• ELCC 2022, Survivorship Session
• ASCO 2022, Real-World Data to Clinical Trials Patient Perspective
• NLCRT Annual Meeting 2022, I Don’t Want to Survive: I Want to Live
• ASTRO 2021, Presidential Symposium, RWD vs RCT Patient Perspective
• AAADV Conference 2021, PROs in the drug development
• IASLC, WCLC 2021 Stigma Plenary, Words Matter
• IASLC, WCLC 2020 Plenary Diversifying Eligibility Criteria in Clinical Trials, Health Disparities
• IASLC, WCLC Press Conference 2020, Patient Perspective Disparity Abstracts
• IASLC, NACLC Keynote session 2020, The Paradigm Shift in Early-Stage Lung Cancer: Bringing the Patient Back into Personalized Medicine
• ASCO, Education Program 2020, Lost in Translation: Patient Perspective on Patient on Communication in the Era of Precision Medicine
• AACR-IASLC Joint Conference Lung Cancer Translational Science 2020, How Lung Cancer Advocates and Patient Groups Help Accelerate Research
• IASLC, NACLC 2019, How Research and Advocacy Has Changed in Past Years
• IASLC, WCLC Press Conference 2018, What Practice Changing Research Means to Patients
• ECOG-ACRIN 2019, Oncogene-Driven Patient Groups: Involving Patient Advocates in Research
• IASLC WCLC Press Conference 2018, Patient Perspective on Practice Changing Abstracts
• IASLC, WCLC 2017, Press Conference, Care Team Award Speech and Presentation
• Grand Rounds
• Henry Ford Cancer Center Grand Rounds, 2023
• Rush Supportive Oncology Grand Rounds, 2023
• Ellison Institute, 2022
• Massachusetts General Hospital Grand Rounds, 2021
• Houston Methodist Cancer Center, 2020
• GRACE Targeted Therapies 2019, Online Communities-Support, Education, Partnership and Facilitating Research
• Other speaking events
• DC Lung 2023, The Art of Oncology: Learning from Patients’ Lived Experience
• OCS Director’s Series 2022, Beyond Prognostic Information – What Survivors Need
• AACR 2022, Transformative Potential of Biomarkers Patient Perspective
• Oncology Nursing Society Chapter Meetings, 2020, Oncology Nurse Perspectives in the Era of Precision Medicine
• OncoAlert Colloquium 2020, What Cancer Research Means to Patients and Families
• Oncology Nursing Society, 2019, Panel member for Best Practices in Biomarker Testing
• Northwest Community, Shine a Light, 2018
• Rush Nursing Summit, 2016 Working with Patient Advocates
• University of Chicago, Nursing School, 2016-2018
• Northwestern University, Nursing Conference, 2013
• LUNGevity Foundation, Breathe Deep North Shore, 2012-2016, 2019

• WGN Chicago News, August 2, 2021, Kathy Griffin’s Lung Cancer Diagnosis Shines a Light on Need for Better Awareness, Treatment
• Today Show, November 14, 2019, Shining a Light: Going Behind the Stigma Surrounding Lung Cancer
• Culver Academies Alumni Magazine, Spring 2020, Feature Article Jill Feldman Advocate, Instructor and Educator
• NBC Chicago Sports, 2017, Jill Feldman’s Special Night with the Bears
• Cure, November 14, 2017, Examining the Relationship Between Stress and Lung Cancer
• AtlanticLIVE, 2017, The Lung Cancer Connection/The Air We Breathe
• CBS News Chicago, May 13, 2014, New Initiative Aims To Raise Awareness For Lung Cancer

• Ending Stigma in Lung Cancer: The IASLC Participates in a Collaborative Summit Held by the National Lung Cancer Roundtable, 2020
• Lung Cancer Health Care Delivery, Community Building and Research: Are They Truly Inclusive? 2020
• LungCancer.net blogs
• LUNGEVITY FOUNDATION, Chicago, Illinois
• President-Board of Directors
• 2007-2010
• Review and reassess mission and vision for organization
• Strategize and develop plans for future fundraising activities, organizational growth, alliance relationships, infrastructure, research needs, and marketing activity
• Operate as organization’s media liaison
• Vice President-Board of Directors
• 2005-2006
• Managed all functions and activities of organization’s staff
• Organized procedures and presentations of board meetings
• Chairman of Development
• 2001-2005
• Oversaw all operations of both event and non-event fundraising activities
• Managed teams of committee members responsible for developing fundraising ideas, implementation of those ideas, and the assessment of successfulness
• Recruited, trained and coordinated 100+ volunteers on soliciting donations and sponsorships, and history, culture and uniqueness of organization
• Coordinated with the communications committee to produce a newsletter, brochure, website and media kits for development of organization
• LUNGEVITY Accomplishments
• Named 2007 Charity Navigator Fastest Growing Charity
• Increased fundraising totals from $150,000 in 2002 to $4+ million in 2008
• Raised over $1 million through 33 national fundraising events in 2007
• Developed sponsorship programs which increased event sponsorship more than 200% from 2002 to 2006.
• Asco post newsreal

• IASLC, WCLC 2023, OA Recognizing Early Adopters of Non-Stigmatizing Language at IASLC WCLC2022
• IASLC WCLC 2020, Mini OA How Lung Cancer Patients Perceive their Treating Doctors and Engage in Medical Decision Making
• IASLC, NACLC 2020, Mini OA The Paradigm Shift in Treating Early Stage Lung Cancer
• IASLC, NACLC 2019, Mini OA Impact of an EGFR Lung Cancer Diagnosis on Quality of Life
• Panels, Workshops, Symposia
• FOCR FDA, Oncology Real World Data Research Annual Roundtable, 2023
• LUNGevity FDA, Statistical Forum on Crossover in Oncology Clinical Trials, 2023
• HHS Beyond Altruism – Exploring Payment for Research Participation, 2022
• ASCO FDA Workshop, Getting the Dose Right: Optimizing Dose Selection Strategies in Oncology, 2022
• FDA Conversations on Cancer, More isn’t Always Better: Understanding Treatment Tolerability, 2022
• FDA COA-CCT, Physical Function, 2021
• FDA OCE, Project Livin’ Label, 2021
• FDA OCE, Defining Clinical Benefit: Applications of Accelerated Approval in Lung Cancer and Precision Medicine, 2021